Significant Ownership of Frazier Life Sciences X, L.P.

Signature - Title
/s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
Location
Seattle, WA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences X, L.P..

Notify me when Frazier Life Sciences X, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Frazier Life Sciences X, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NAMS NEWAMSTERDAM PHARMA COMPANY N.V. Ordinary Shares, nominal value EUR0.12 per share 7.7% $245M $36.9M 8.62M +17.7% Frazier Life Sciences Public Fund, L.P. 01 Nov 2025

Schedules 13D/G Reported by Frazier Life Sciences X, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.